Research progress in biological targeted therapy drugs for lupus nephritisCHEN Ming, LIN Jin, CAO Heng2225-2233
An overview of phosphodiesterase 4 inhibitors in the treatment of rheumatic autoimmune diseasesLIU Ye-ling, ZHENG Wen-jie2240-2245
Safety of biological agents in patients with rheumatoid arthritis during the peri-conceptional period and their potential influence on maternal-fetal vaccinationOUYANG Zhi-ming, CHEN Le-feng, DAI Lie2246-2251
The role and mechanism of low dose IL-2 in infectious diseasesZHU Yan, FANG Shi-lin, HE Jing2252-2256
A retrospective study of rituximab for treatment of lupus mesenteric vasculitis and improvement of intestinal damageWANG Bei, CHENG Gong, LI Hao, WANG Nai-di, ZHAO Ya-yun, FENG Rui-ling, JIN Yue-bo, HE Jing2257-2263
The effect of Qingre Lishi Huoxue method combined with iguratimod tablets on bone metabolism and clinical efficacy observation in treating primary rheumatoid arthritisZHANG Di, WANG Ping, LIU Ying, JIANG Ping, ZHOU Hai-rong, FAN Bing, LI Da-ke2264-2269
Evaluation of reproductive system safety of thalidomide in 214 women of childbearing age with rheumatic diseasesLI Jian-bin, CHI Qiang, LIU Peng-cheng, WU Rui2270-2274
A Meta analysis of hepatitis B reactivation associated with tumor necrosis factor-α inhibitors in rheumatoid arthritisYANG Jian-guo, SUN Yu-ying, CAO Jiao-jiao, FAN Bing2275-2283
Analysis of clinical trials registration for ankylosing spondylitis based on data on the web of ClinicalTrials.govBAI Li-na, MIAO Hua-li, LI Wan-ling, SU Yan-bing, FAN Xiu-ying, ZHANG Li-yun2284-2292